AMY BRYANT: Open Payments
NPI 1356384978 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 38 payments from 23 companies in 2025. Trend: 2023 $814 · 2024 $955 · 2025 $945
Food & beverage: $865Education: $80
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| Daiichi Sankyo Inc. | 2 | $58 |
| Gilead Sciences, Inc. | 2 | $54 |
| Incyte Corporation | 2 | $47 |
| ABBVIE INC. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| SpringWorks Therapeutics, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: LYNPARZA, KISQALI, Trodelvy, ENHERTU, GOMEKLI, OPDIVO, Vonjo, INJECTAFER.
Industry payments across TN — which companies pay providers there.
